Advisory Committee on Immunization Practices (ACIP) Charter Renewal
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The CDC has renewed the charter of the Advisory Committee on Immunization Practices (ACIP) for two more years, extending it through April 1, 2028. ACIP is the federal advisory committee that develops vaccine recommendations adopted by the CDC Director, which then become official U.S. immunization guidance. These recommendations determine which vaccines are covered by private insurance under the Affordable Care Act and which vaccines are provided through the Vaccines for Children Program. The committee consists of up to 19 voting members selected for expertise and balanced representation across geography, specialties, and viewpoints.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Charter renewed for 2 years through April 1, 2028
- Committee maintains up to 19 voting members
- Annual operating cost estimated at $1,206,196
+ 3 more changes with Pro
Obligations
What this law requires
CDC must consult with General Services Administration's Committee Management Secretariat and provide written public interest determination approved by agency head before renewing ACIP charter
CDC must ensure ACIP committee membership is fairly balanced in terms of points of view represented and considers geographic diversity and diverse specialty areas during member selection
CDC must solicit ACIP membership applications through continuous process, annual Federal Register posting, at ACIP meetings, and via website at https://www.cdc.gov/acip/membership/index.html
HHS Secretary must select and appoint ACIP members, including Chair and Vice Chair, for overlapping terms of up to four years
ACIP must establish and periodically review the list of vaccines for the Vaccines for Children Program, including schedules for appropriate dose, dosing intervals, and contraindications